Skip to main content

Table 2 Adverse effects of treatment experienced by patients included in the study

From: Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial

Adverse effect group T
(n = 18)
group N
(n = 17)
p
Arthralgia 7 (38.9%) 1 (5.9%) 0.041
Myalgia 3 (16.7%) 1 (5.9%) 0.603
Persistent breakthrough bleeding 0 (0.0%) 2 (11.8%) 0.229
Depression 4 (22.2%) 1 (5.9%) 0.338
Insomnia 3 (16.7%) 0 (0.0%) 0.229
Decreased libido 4 (22.2%) 2 (11.8%) 0.658
Vaginal dryness 3 (16.7%) 0 (0.0%) 0.229
Hot flushes 4 (22.2%) 0 (0.0%) 0.104
Hair loss 2 (11.1%) 0 (0.0%) 0.486
Headache 2 (11.1%) 0 (0.0%) 0.486
Weight gain 1 (5.6%) 2 (11.8%) 0.603
At least one adverse effect 14 (77.8%) 6 (35.3%) 0.018